Inventor
ZHU YUNFEI
US30 patents
⚠️ This page may combine multiple inventors who share the name “ZHU YUNFEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CRINETICS PHARMACEUTICALS INC
24 patentsUS10696689B2Jun 30, 2020
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC12 citations86
US11186590B2Nov 30, 2021
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC6 citations84
US10981894B2Apr 20, 2021
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
CRINETICS PHARMACEUTICALS INC6 citations84
US10875839B2Dec 29, 2020
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC5 citations84
US10766877B2Sep 8, 2020
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
CRINETICS PHARMACEUTICALS INC7 citations84
US10604507B2Mar 31, 2020
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
CRINETICS PHARMACEUTICALS INC7 citations84
US10597377B2Mar 24, 2020
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC8 citations84
US10562884B2Feb 18, 2020
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
CRINETICS PHARMACEUTICALS INC7 citations84
US10351547B2Jul 16, 2019
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC9 citations84
US9957267B2May 1, 2018
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC8 citations84
US9902703B2Feb 27, 2018
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC8 citations84
US9896432B2Feb 20, 2018
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC11 citations84
US11834462B2Dec 5, 2023
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC2 citations73
US11566015B2Jan 31, 2023
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
CRINETICS PHARMACEUTICALS INC2 citations73
US11414397B2Aug 16, 2022
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC2 citations73
US11072598B2Jul 27, 2021
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC6 citations73
US11479540B2Oct 25, 2022
Nonpeptide somatostatin type 5 receptor agonists and uses thereof
CRINETICS PHARMACEUTICALS INC5 citations72
US12479828B2Nov 25, 2025
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
CRINETICS PHARMACEUTICALS INC0 citations62
US12134610B2Nov 5, 2024
Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof
CRINETICS PHARMACEUTICALS INC1 citations62
US11608335B2Mar 21, 2023
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC2 citations62
US12492181B2Dec 9, 2025
Gem-disubstituted piperidine melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
CRINETICS PHARMACEUTICALS INC0 citations52
US12479825B2Nov 25, 2025
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
CRINETICS PHARMACEUTICALS INC0 citations52
US12466829B2Nov 11, 2025
Spirocyclic piperidine melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
CRINETICS PHARMACEUTICALS INC0 citations52
US11028068B2Jun 8, 2021
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC0 citations52